✦ LIBER ✦

Calcineurin inhibitors in renal transplantation: is tacrolimus a superior agent?

✍ Scribed by Yves VANRENTERGHEM

Book ID: 108958666
Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 236 KB
Volume: 7
Category: Article
ISSN: 1320-5358
DOI: 10.1111/j.1440-1797.2002.tb00499.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Protease inhibitors and diltiazem increa

Protease inhibitors and diltiazem increase tacrolimus blood concentration in a patient with renal transplantation: a case report

✍ Gaëlle Hardy; Françoise Stanke-Labesque; Claudine Contamin; Françoise Serre-Debe 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 167 KB

Tacrolimus is highly effective in both d

Tacrolimus is highly effective in both dual and triple therapy regimens following renal transplantation

✍ G. Segoloni; V. Bonomini; M. C. Maresca; L. Arisi; M. Gonzalez-Molina; A. Tarant 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 62 KB

Improvement of renal function after the

Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction

✍ Javier F. Castroagudín; Esther Molina; Rafael Romero; Esteban Otero; Santiago To 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Chronic renal dysfunction is a frequent and severe complication in solid-organ transplant recipients. Calcineurin inhibitors (CNIs) are the main pathogenic factors of renal dysfunction. Switching from CNIs to nonnephrotoxic drugs, such as mammalian target of rapamycin inhibitors (everolimus and siro

Use of sirolimus and low-dose calcineuri

Use of sirolimus and low-dose calcineurin inhibitor in lung transplant recipients with renal impairment: Results of a controlled pilot study

✍ Shitrit, David; Rahamimov, Ruth; Gidon, Sahar; Bakal, Ilana; Bargil-Shitrit, Ari 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 73 KB

Impact ofCYP3A5andCYP3A4gene polymorphis

Impact ofCYP3A5andCYP3A4gene polymorphisms on dose requirement of calcineurin inhibitors, cyclosporine and tacrolimus, in renal allograft recipients of North India

✍ Ranjana Singh; Aneesh Srivastava; Rakesh Kapoor; Raj K. Sharma; Rama D. Mittal 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 244 KB

A randomized controlled trial of late co

A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function

✍ Christopher J.E. Watson; Alexander E.S. Gimson; Graeme J. Alexander; Michael E.D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 1 views

Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a sin